TIDI Executive and Leadership Team

Jim Rubright, the President & Chief Executive Officer at TIDI, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the entire product portfolio, the President & Chief Executive Officer ensures that infection-control standards remain at the forefront of all manufacturing processes. This leadership role involves constant collaboration with the Board to drive sustainable growth across North American healthcare markets. By aligning internal resources with evolving clinical needs, Jim Rubright maintains the company's competitive edge in the medical manufacturing sector. The President & Chief Executive Officer monitors market trends to identify opportunities for expanding the reach of protective equipment. Through rigorous oversight of organizational performance, the President & Chief Executive Officer secures the financial health and operational integrity of the enterprise. This executive leadership fosters a culture of safety and innovation, ensuring that every product meets the critical requirements of hospitals and clinics.

Amy Zemke, the Chief Financial Officer at TIDI, manages the fiscal health and capital allocation strategies for the entire organization. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures that resources support the production of critical infection-control supplies. This leadership role involves maintaining robust internal controls while optimizing the cost structure of manufacturing operations. By analyzing market data, Amy Zemke provides the strategic insights necessary for informed decision-making across the executive team. The Chief Financial Officer coordinates with department heads to align budgetary goals with the company's mission of enhancing clinical safety. Through precise financial modeling, the Chief Financial Officer drives efficiency in supply chain investments and capital expenditures. This executive leadership supports the long-term stability of the company, ensuring that fiscal performance remains consistent with the high standards required for medical-grade personal protection equipment and clinical supplies.

Jeff Hebbard, the Vice President & Chief Operating Officer at TIDI, directs the daily manufacturing operations and supply chain logistics for the company. Overseeing the production of table paper, sponges, and personal protection equipment, the Vice President & Chief Operating Officer ensures that every item meets stringent quality standards. This leadership role involves optimizing factory throughput and streamlining distribution channels to meet the demands of hospitals and clinics. By implementing lean manufacturing principles, Jeff Hebbard enhances operational efficiency across all production facilities. The Vice President & Chief Operating Officer collaborates with the executive team to scale output in response to global infection-control needs. Through the management of complex logistics, the Vice President & Chief Operating Officer guarantees the timely delivery of critical medical supplies. This executive leadership maintains the operational excellence required to support the company's commitment to patient and provider safety in diverse healthcare environments.

James Devlin, the President at TIDI, leads specific business units focused on market expansion and product development within the medical manufacturing sector. Overseeing the commercialization of new infection-control solutions, the President ensures that the company addresses the evolving needs of clinics and offices. This leadership role involves driving regional growth initiatives and strengthening relationships with key healthcare partners. By identifying emerging market segments, James Devlin expands the footprint of the company's protective equipment portfolio. The President coordinates with cross-functional teams to accelerate the development of innovative gauze, masks, and gowns. Through strategic market analysis, the President identifies opportunities to increase the adoption of single-use products in critical care settings. This executive leadership supports the company's mission by ensuring that high-quality, reliable infection-control tools reach the professionals who rely on them daily for maintaining safe and sterile environments.